Nanjing Vishee Medical Technology Co Ltd (688580) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, Nanjing Vishee Medical Technology Co Ltd (688580) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥42.79 Million ≈ $6.26 Million USD) by net assets (CN¥1.66 Billion ≈ $242.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688580 market cap overview for the company's overall valuation and market capitalisation.

Nanjing Vishee Medical Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Nanjing Vishee Medical Technology Co Ltd (688580) share price today for real-time trading data and today's change.

Nanjing Vishee Medical Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing Vishee Medical Technology Co Ltd ranked by their cash flow conversion efficiency. Review 688580 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Shanghai GuAo Electronic Technology Co Ltd
SHE:300551
-0.038x
Floridienne
BR:FLOB
0.106x
JINXIN FERT.GRP HD-00001
F:3NX
N/A
Guangzhou Grandbuy Co Ltd
SHE:002187
0.021x
Arvind Fashions Limited
NSE:ARVINDFASN
0.103x
PRINC.PR.EQ.HLDGS EO-001
F:PEYA
N/A
Foshan Nationstar Optoelectronics Co Ltd
SHE:002449
0.024x
Shanghai Conglin Environmental Protection Technology Co. Ltd. A
SHG:688370
N/A

Annual Cash Flow Conversion Efficiency for Nanjing Vishee Medical Technology Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Nanjing Vishee Medical Technology Co Ltd from 2013 to 2025. Also see Nanjing Vishee Medical Technology Co Ltd (688580) total assets for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.69 Billion
≈ $247.75 Million
CN¥176.74 Million
≈ $25.86 Million
0.104x +43.63%
2024-12-31 CN¥1.63 Billion
≈ $238.15 Million
CN¥118.29 Million
≈ $17.31 Million
0.073x -11.90%
2023-12-31 CN¥1.63 Billion
≈ $238.05 Million
CN¥134.20 Million
≈ $19.64 Million
0.082x +46.34%
2022-12-31 CN¥1.53 Billion
≈ $223.67 Million
CN¥86.17 Million
≈ $12.61 Million
0.056x -45.08%
2021-12-31 CN¥1.53 Billion
≈ $224.34 Million
CN¥157.37 Million
≈ $23.03 Million
0.103x +19.93%
2020-12-31 CN¥1.41 Billion
≈ $206.47 Million
CN¥120.76 Million
≈ $17.67 Million
0.086x -84.58%
2019-12-31 CN¥254.86 Million
≈ $37.29 Million
CN¥141.47 Million
≈ $20.70 Million
0.555x +26.84%
2018-12-31 CN¥196.16 Million
≈ $28.70 Million
CN¥85.84 Million
≈ $12.56 Million
0.438x +28.26%
2017-12-31 CN¥153.42 Million
≈ $22.45 Million
CN¥52.35 Million
≈ $7.66 Million
0.341x +30.17%
2016-12-31 CN¥118.20 Million
≈ $17.30 Million
CN¥30.98 Million
≈ $4.53 Million
0.262x +10.44%
2015-12-31 CN¥106.25 Million
≈ $15.55 Million
CN¥25.22 Million
≈ $3.69 Million
0.237x -2.51%
2014-12-31 CN¥61.64 Million
≈ $9.02 Million
CN¥15.01 Million
≈ $2.20 Million
0.243x +14.83%
2013-12-31 CN¥38.81 Million
≈ $5.68 Million
CN¥8.23 Million
≈ $1.20 Million
0.212x --

About Nanjing Vishee Medical Technology Co Ltd

SHG:688580 China Medical Devices
Market Cap
$582.16 Million
CN¥3.98 Billion CNY
Market Cap Rank
#11499 Global
#3283 in China
Share Price
CN¥41.54
Change (1 day)
-0.19%
52-Week Range
CN¥40.50 - CN¥69.70
All Time High
CN¥207.27
About

Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) device, and MagNeuro ONE, a TMS therapy system with navigation for psychiatric and neurological applications. It also provides MagBelle, a pelvic floor muscle stimulator for the treatment of urinar… Read more